Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura (Q64151574)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura |
clinical trial |
Statements
HERCULES (English)
0 references
A Phase III Double-blind, Randomized, Parallel Group, Multicenter Placebo-controlled Trial to Study the Efficacy and Safety of Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura (English)
0 references
November 2015
0 references
August 2017
0 references
145
0 references
18 year
0 references